Clinical trial
A Multicenter, Randomized, Single-blind, Active-controlled Trial of The Efficacy and Safety of Polyene Phosphatidylcholine in Patients With Acute Drug-induced Liver Injury
NCT04595916 is registered in ClinicalTrials.gov with Sichuan Haisco Pharmaceutical Group Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Single-blind, Active-controlled Trial of The Efficacy and Safety of Polyene Phosphatidylcholine in Patients With Acute Drug-induced Liver Injury
- Lead sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 4, 2020
- Completion date
- November 2, 2020
- Enrollment
- 73 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
acute drug induced liver injury